Expert Opinion on Drug Discovery,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 19
Published: Dec. 24, 2024
Autism
spectrum
disorder
(ASD)
is
a
prevalent
and
complex
neurodevelopmental
(NDD)
with
genetic
environmental
origins.
Currently,
there
are
no
effective
pharmacological
treatments
targeting
core
ASD
features.
This
leads
to
unmet
medical
needs
of
individuals
requires
relevant
human
disease
models
recapitulating
clinical
heterogeneity
better
understand
underlying
mechanisms
identify
potential
therapies.
Recent
advancements
in
stem
cell
technology
have
enabled
the
generation
pluripotent
(hPSC)-derived
two-dimensional
(2D)
three-dimensional
(3D)
neural
models,
which
serve
as
powerful
tools
for
modeling
drug
discovery.
Autism Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 24, 2025
Autism
spectrum
disorder
(ASD)
is
a
complex
neuro
developmental
condition
characterized
by
significant
genetic
and
phenotypic
variability,
making
diagnosis
treatment
challenging.
The
heterogeneity
of
ASD-associated
variants
the
absence
clear
causal
factors
in
many
cases
complicate
personalized
care.
Traditional
models,
such
as
postmortem
brain
tissue
animal
studies,
have
provided
valuable
insights
but
are
limited
capturing
dynamic
processes
human-specific
aspects
ASD
pathology.
Recent
advances
human
induced
pluripotent
stem
cell
(iPSC)
technology
transformed
research
enabling
generation
patient-derived
neural
cells
both
two-dimensional
cultures
three-dimensional
organoid
models.
These
models
retain
donor's
background,
allowing
researchers
to
investigate
disease-specific
cellular
molecular
mechanisms
while
identifying
potential
therapeutic
targets
tailored
individual
patients.
This
commentary
highlights
how
cell-based
approaches
advancing
our
understanding
paving
way
for
more
diagnostic
strategies.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 5, 2025
Social
behavior
is
critical
for
survival
and
adaptation,
which
profoundly
disrupted
in
autism
spectrum
disorders
(ASD).
withdrawal
due
to
information
overload
was
often
described
ASD,
it
suspected
that
increased
basal
noise,
i.e.,
excessive
background
neuronal
activities
the
brain
could
be
a
disease
mechanism.
However,
experimental
test
of
this
hypothesis
limited.
Loss-of-function
mutations
(deficiency)
SCN2A
,
encodes
voltage-gated
sodium
channel
Na
V
1.2,
have
been
revealed
as
leading
monogenic
cause
profound
ASD.
Here,
we
Scn2a
deficiency
results
robust
multifaceted
social
impairments
mice.
-deficient
neurons
displayed
an
excitation-inhibition
(E/I)
ratio,
contributing
elevated
noise
diminished
signal-to-noise
ratio
(SNR)
during
interactions.
Notably,
restoration
expression
adulthood
able
rescue
both
SNR
deficits.
By
balancing
E/I
reducing
firing,
FDA-approved
GABA
A
receptor-positive
allosteric
modulator
improves
sociability
mice
normalizes
translationally
relevant
human
organoids
carrying
autism-associated
nonsense
mutation.
Collectively,
our
findings
role
1.2
regulation
behaviors,
identified
molecular,
cellular,
circuitry
mechanisms
underlying
-associated
disorders.
leads
pronounced
deficits
overall
enhanced
activity,
impaired
ratio.
Both
are
reversible
through
adulthood.
Targeted
striatum-projecting
rescues
impairments.
transmission
reduced
mouse
organoid
models
deficiency,
acute
systemic
administration
modulators
restores
sociability.
Graphical
abstract:
Severe
predominate
decrease
with
SNR,
adult
1.2-deficient
Frontiers in Psychiatry,
Journal Year:
2024,
Volume and Issue:
15
Published: April 25, 2024
Autism
spectrum
disorder
(ASD)
is
a
neurodevelopmental
that
encompasses
range
of
symptoms
including
difficulties
in
verbal
communication,
social
interaction,
limited
interests,
and
repetitive
behaviors.
Neuroplasticity
refers
to
the
structural
functional
changes
occur
nervous
system
adapt
respond
external
environment.
In
simpler
terms,
it
brain's
ability
learn
new
environments.
However,
individuals
with
ASD
exhibit
abnormal
neuroplasticity,
which
impacts
information
processing,
sensory
cognition,
leading
manifestation
corresponding
symptoms.
This
paper
aims
review
current
research
progress
on
focusing
genetics,
environment,
neural
pathways,
neuroinflammation,
immunity.
The
findings
will
provide
theoretical
foundation
insights
for
intervention
treatment
pediatric
fields
related
ASD.
Advanced Materials Technologies,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 8, 2025
Abstract
Human
brain
organoids,
which
originate
from
pluripotent
stem
cells,
serve
as
valuable
tools
for
a
wide
range
of
research
endeavors,
replicating
function.
Their
capacity
to
replicate
cellular
interactions,
morphology,
and
division
provides
invaluable
insights
into
development,
disease
modeling,
drug
screening.
However,
conventional
morphological
analysis
methods
are
often
invasive
lack
real‐time
monitoring
capabilities,
posing
limitations
achieving
comprehensive
understanding.
Therefore,
advancing
the
comprehension
organoid
electrophysiology
necessitates
development
minimally
measurement
technologies
with
long‐term,
high‐resolution
capabilities.
This
review
highlights
significance
human
organoids
emphasizes
need
electrophysiological
characterization.
It
delves
assessment
methods,
particularly
focusing
on
3D
microelectrode
arrays,
electrode
insertion
mechanisms,
importance
flexible
arrays
facilitate
recordings.
Additionally,
various
sensors
tailored
monitor
properties
introduced,
enriching
understanding
their
chemical,
thermal,
mechanical
dynamics.
Proceedings of the National Academy of Sciences,
Journal Year:
2025,
Volume and Issue:
122(16)
Published: April 16, 2025
Various
pathological
characteristics
of
autism
spectrum
disorder
(ASD)
stem
from
abnormalities
in
brain
resident
immune
cells,
specifically
microglia,
to
prune
unnecessary
synapses
or
neural
connections
during
early
development.
Animal
models
ASD
exhibit
an
abundance
different
regions,
which
is
strongly
linked
the
appearance
behaviors.
Overexpression
CD47
on
neurons
acts
as
a
“don’t
eat
me”
signal,
safeguarding
inappropriate
pruning
by
microglia.
Indeed,
overexpression
occurs
16p11.2
deletion
carriers,
causing
decreased
synaptic
phagocytosis
and
manifestation
characteristics.
However,
role
impairment
leading
phenotypes
mouse
model
unclear.
Moreover,
whether
blocking
can
alleviate
mice’s
behavioral
deficits
remains
unknown.
Here,
we
demonstrate
strong
link
between
increased
expression,
microglia
capacity,
social
novelty
preference
mice.
The
reduction
caused
rise
excitatory
transmission
prefrontal
cortex
Importantly,
using
specific
antibody
reducing
expression
short
hairpin
RNA
(shRNA)
enhanced
reduced
transmission.
Reduction
improved
These
findings
that
associated
with
mice
could
be
promising
target
for
development
treatment
ASD.
Proceedings of the National Academy of Sciences,
Journal Year:
2025,
Volume and Issue:
122(21)
Published: May 19, 2025
Insulin
receptors
are
present
on
cells
throughout
the
body,
including
brain.
Dysregulation
of
insulin
signaling
in
neurons
and
astrocytes
has
been
implicated
altered
mood,
cognition,
pathogenesis
Alzheimer’s
disease
(AD).
To
define
role
microglia,
primary
phagocytes
brain
critical
for
maintenance
damage
repair,
we
created
mice
with
an
inducible
microglia-specific
receptor
knockout
(MG-IRKO).
RiboTag
profiling
microglial
mRNAs
revealed
that
loss
results
alterations
gene
expression
pathways
related
to
innate
immunity
cellular
metabolism.
In
vitro,
microglia
metabolic
reprogramming
increase
glycolysis
impaired
uptake
Aβ.
vivo,
MG-IRKO
exhibit
mood
social
behavior,
when
crossed
5xFAD
mouse
model
AD,
resultant
increased
levels
Aβ
plaque
elevated
neuroinflammation.
Thus,
plays
a
key
metabolism
ability
take
up
Aβ,
such
reduced
alters
behavior
accelerates
AD
pathogenesis.
Together,
these
data
indicate
roles
action
potential
targeting
treatment
AD.